These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 25584165

  • 21. The antiglucocorticoid and antiprogestin steroid RU 486 suppresses the adrenocorticotropin response to ovine corticotropin releasing hormone in man.
    Laue L, Chrousos GP, Loriaux DL, Barnes K, Munson P, Nieman L, Schaison G.
    J Clin Endocrinol Metab; 1988 Feb; 66(2):290-3. PubMed ID: 2828406
    [Abstract] [Full Text] [Related]

  • 22. Effects of repetitive administration of corticotropin-releasing hormone combined with lysine vasopressin on plasma adrenocorticotropin and cortisol levels in secondary adrenocortical insufficiency.
    Fukata J, Usui T, Tsukada T, Nakai Y, Koh T, Ishihara T, Tanaka I, Uchida K, Yoshimasa T, Nakano R.
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1624-31. PubMed ID: 2172283
    [Abstract] [Full Text] [Related]

  • 23. Iatrogenic Cushing's syndrome in children presenting at Children's Hospital Lahore using nappy rash ointments.
    Sattar H, Manzoor J, Mirza L, Sheikh AM, Butt TA.
    J Pak Med Assoc; 2015 May; 65(5):463-6. PubMed ID: 26028377
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Diagnosis and management of Cushing's syndrome: results of an Italian multicentre study. Study Group of the Italian Society of Endocrinology on the Pathophysiology of the Hypothalamic-Pituitary-Adrenal Axis.
    Invitti C, Pecori Giraldi F, de Martin M, Cavagnini F.
    J Clin Endocrinol Metab; 1999 Feb; 84(2):440-8. PubMed ID: 10022398
    [Abstract] [Full Text] [Related]

  • 27. Adrenocorticotropin- and cortisol-releasing effect of hexarelin, a synthetic growth hormone-releasing peptide, in normal subjects and patients with Cushing's syndrome.
    Ghigo E, Arvat E, Ramunni J, Colao A, Gianotti L, Deghenghi R, Lombardi G, Camanni F.
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2439-44. PubMed ID: 9253314
    [Abstract] [Full Text] [Related]

  • 28. Topical-steroid-induced iatrogenic Cushing syndrome in the pediatric age group: A rare case report.
    Tiwari A, Goel M, Pal P, Gohiya P.
    Indian J Endocrinol Metab; 2013 Oct; 17(Suppl 1):S257-8. PubMed ID: 24251179
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. A Case of Severe Psychosis Due to Cushing's Syndrome Secondary to Primary Bilateral Macronodular Adrenal Hyperplasia.
    Shah K, Mann I, Reddy K, John G.
    Cureus; 2019 Nov 15; 11(11):e6162. PubMed ID: 31890370
    [Abstract] [Full Text] [Related]

  • 31. The low-dose dexamethasone suppression test in patients with adrenal incidentalomas: comparisons with clinically euadrenal subjects and patients with Cushing's syndrome.
    Tsagarakis S, Kokkoris P, Roboti C, Malagari C, Kaskarelis J, Vlassopoulou V, Alevizaki C, Thalassinos N.
    Clin Endocrinol (Oxf); 1998 May 15; 48(5):627-33. PubMed ID: 9666875
    [Abstract] [Full Text] [Related]

  • 32. [Development of Cushing's syndrome during phytotherapy].
    Bernecker C, Hartung B, Maser-Gluth C, Schott M, Willenberg HS.
    Dtsch Med Wochenschr; 2013 Aug 15; 138(33):1659-63. PubMed ID: 23913352
    [Abstract] [Full Text] [Related]

  • 33. The corticotropin-releasing hormone test in the postoperative evaluation of patients with cushing's syndrome.
    Avgerinos PC, Chrousos GP, Nieman LK, Oldfield EH, Loriaux DL, Cutler GB.
    J Clin Endocrinol Metab; 1987 Nov 15; 65(5):906-13. PubMed ID: 3499448
    [Abstract] [Full Text] [Related]

  • 34. Residual adrenocortical function after bilateral adrenalectomy for pituitary-dependent Cushing's syndrome.
    Kemink L, Hermus A, Pieters G, Benraad T, Smals A, Kloppenborg P.
    J Clin Endocrinol Metab; 1992 Nov 15; 75(5):1211-4. PubMed ID: 1331164
    [Abstract] [Full Text] [Related]

  • 35. A natural history of adrenocorticotropin-independent bilateral adrenal macronodular hyperplasia (AIMAH) from preclinical to clinically overt Cushing's syndrome.
    Ohashi A, Yamada Y, Sakaguchi K, Inoue T, Kubo M, Fushimi H.
    Endocr J; 2001 Dec 15; 48(6):677-83. PubMed ID: 11873866
    [Abstract] [Full Text] [Related]

  • 36. Effectiveness versus efficacy: the limited value in clinical practice of high dose dexamethasone suppression testing in the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome.
    Aron DC, Raff H, Findling JW.
    J Clin Endocrinol Metab; 1997 Jun 15; 82(6):1780-5. PubMed ID: 9177382
    [Abstract] [Full Text] [Related]

  • 37. Iatrogenic Cushing's Syndrome Due to Topical Ocular Glucocorticoid Treatment.
    Fukuhara D, Takiura T, Keino H, Okada AA, Yan K.
    Pediatrics; 2017 Feb 15; 139(2):. PubMed ID: 28104732
    [Abstract] [Full Text] [Related]

  • 38. Adult iatrogenic Cushing's syndrome induced by topical skin corticosteroid misuse.
    Negrini S, Murdaca G, Ferone D, Borro M.
    Therapie; 2019 Oct 15; 74(5):547-549. PubMed ID: 31023618
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.